Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6765 | 1446 | 49.1 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
76 | 3 | NEUROSCIENCES//DOPAMINE//SEROTONIN | 81359 |
75 | 2 | NUCLEUS ACCUMBENS//DOPAMINE//COCAINE | 27976 |
6765 | 1 | KAPPA OPIOID RECEPTOR//BIOL ADDICT DIS//DYNORPHIN | 1446 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | KAPPA OPIOID RECEPTOR | authKW | 718781 | 10% | 23% | 146 |
2 | BIOL ADDICT DIS | address | 332484 | 5% | 24% | 67 |
3 | DYNORPHIN | authKW | 307617 | 7% | 14% | 104 |
4 | JDTIC | authKW | 168916 | 1% | 67% | 12 |
5 | SPEEDBALL | authKW | 158970 | 1% | 47% | 16 |
6 | U 69593 | authKW | 153242 | 1% | 48% | 15 |
7 | COCAINE | authKW | 142333 | 17% | 3% | 244 |
8 | PRODYNORPHIN | authKW | 134622 | 2% | 25% | 26 |
9 | ALCOHOLISM ADDICT NEUROSCI | address | 131560 | 1% | 69% | 9 |
10 | KAPPA OPIOID | authKW | 106117 | 2% | 17% | 30 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 17107 | 62% | 0% | 902 |
2 | Pharmacology & Pharmacy | 11234 | 51% | 0% | 742 |
3 | Behavioral Sciences | 3360 | 11% | 0% | 162 |
4 | Psychiatry | 3318 | 18% | 0% | 260 |
5 | Substance Abuse | 1188 | 4% | 0% | 64 |
6 | Medicine, Research & Experimental | 65 | 4% | 0% | 54 |
7 | Chemistry, Medicinal | 40 | 2% | 0% | 34 |
8 | Psychology, Biological | 27 | 1% | 0% | 9 |
9 | Endocrinology & Metabolism | 20 | 3% | 0% | 40 |
10 | Physiology | 9 | 2% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOL ADDICT DIS | 332484 | 5% | 24% | 67 |
2 | ALCOHOLISM ADDICT NEUROSCI | 131560 | 1% | 69% | 9 |
3 | INTEGRAT NEUROSCI UNIT | 98255 | 1% | 42% | 11 |
4 | INTEGRAT NEUROSCI SECT | 83568 | 1% | 23% | 17 |
5 | BEHAV GENET MED | 42231 | 0% | 100% | 2 |
6 | PSYCHOLTRANSLAT ADDICT | 42231 | 0% | 100% | 2 |
7 | PSYCHIATBEHAV GENET | 33780 | 0% | 40% | 4 |
8 | MCLEAN HOSP | 31422 | 4% | 3% | 54 |
9 | AFFECT RISK GAMBLING EXPERIMENTS | 21115 | 0% | 100% | 1 |
10 | BASIC ANAT NEUROBIOL ANESTHESIOL | 21115 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PSYCHOPHARMACOLOGY | 20324 | 7% | 1% | 108 |
2 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 19048 | 7% | 1% | 106 |
3 | SYNAPSE | 12407 | 3% | 1% | 44 |
4 | NEUROPSYCHOPHARMACOLOGY | 10348 | 3% | 1% | 50 |
5 | NEUROPHARMACOLOGY | 7782 | 4% | 1% | 59 |
6 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 7327 | 6% | 0% | 86 |
7 | EUROPEAN JOURNAL OF PHARMACOLOGY | 5992 | 6% | 0% | 90 |
8 | ADDICTION BIOLOGY | 5723 | 1% | 2% | 18 |
9 | BRAIN RESEARCH | 3832 | 7% | 0% | 94 |
10 | BEHAVIOURAL PHARMACOLOGY | 3117 | 1% | 1% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | KAPPA OPIOID RECEPTOR | 718781 | 10% | 23% | 146 | Search KAPPA+OPIOID+RECEPTOR | Search KAPPA+OPIOID+RECEPTOR |
2 | DYNORPHIN | 307617 | 7% | 14% | 104 | Search DYNORPHIN | Search DYNORPHIN |
3 | JDTIC | 168916 | 1% | 67% | 12 | Search JDTIC | Search JDTIC |
4 | SPEEDBALL | 158970 | 1% | 47% | 16 | Search SPEEDBALL | Search SPEEDBALL |
5 | U 69593 | 153242 | 1% | 48% | 15 | Search U+69593 | Search U+69593 |
6 | COCAINE | 142333 | 17% | 3% | 244 | Search COCAINE | Search COCAINE |
7 | PRODYNORPHIN | 134622 | 2% | 25% | 26 | Search PRODYNORPHIN | Search PRODYNORPHIN |
8 | KAPPA OPIOID | 106117 | 2% | 17% | 30 | Search KAPPA+OPIOID | Search KAPPA+OPIOID |
9 | PREPRODYNORPHIN | 101064 | 1% | 32% | 15 | Search PREPRODYNORPHIN | Search PREPRODYNORPHIN |
10 | KAPPA ANTAGONIST | 94055 | 0% | 64% | 7 | Search KAPPA+ANTAGONIST | Search KAPPA+ANTAGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YOO, JH , KITCHEN, I , BAILEY, A , (2012) THE ENDOGENOUS OPIOID SYSTEM IN COCAINE ADDICTION: WHAT LESSONS HAVE OPIOID PEPTIDE AND RECEPTOR KNOCKOUT MICE TAUGHT US?.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 166. ISSUE 7. P. 1993 -2014 | 108 | 57% | 8 |
2 | WEE, S , KOOB, GF , (2010) THE ROLE OF THE DYNORPHIN-KAPPA OPIOID SYSTEM IN THE REINFORCING EFFECTS OF DRUGS OF ABUSE.PSYCHOPHARMACOLOGY. VOL. 210. ISSUE 2. P. 121 -135 | 89 | 54% | 145 |
3 | LALANNE, L , AYRANCI, G , KIEFFER, BL , LUTZ, PE , (2014) THE KAPPA OPIOID RECEPTOR: FROM ADDICTION TO DEPRESSION, AND BACK.FRONTIERS IN PSYCHIATRY. VOL. 5. ISSUE . P. - | 88 | 56% | 14 |
4 | CROWLEY, NA , KASH, TL , (2015) KAPPA OPIOID RECEPTOR SIGNALING IN THE BRAIN: CIRCUITRY AND IMPLICATIONS FOR TREATMENT.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. VOL. 62. ISSUE . P. 51 -60 | 82 | 54% | 5 |
5 | SHIPPENBERG, TS , HENRIKSSON, R , TEJEDA, HA , (2012) THE DYNORPHIN/KAPPA-OPIOID RECEPTOR SYSTEM AND ITS ROLE IN PSYCHIATRIC DISORDERS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 69. ISSUE 6. P. 857 -896 | 137 | 31% | 49 |
6 | CARLEZON, WA , KRYSTAL, AD , (2016) KAPPA-OPIOID ANTAGONISTS FOR PSYCHIATRIC DISORDERS: FROM BENCH TO CLINICAL TRIALS.DEPRESSION AND ANXIETY. VOL. 33. ISSUE 10. P. 895 -906 | 60 | 62% | 0 |
7 | VAN REE, JM , GERRITS, MAFM , VANDERSCHUREN, LJMJ , (1999) OPIOIDS, REWARD AND ADDICTION: AN ENCOUNTER OF BIOLOGY, PSYCHOLOGY, AND MEDICINE.PHARMACOLOGICAL REVIEWS. VOL. 51. ISSUE 2. P. 341 -396 | 159 | 27% | 182 |
8 | CHARTOFF, EH , EBNER, SR , SPARROW, A , POTTER, D , BAKER, PM , RAGOZZINO, ME , ROITMAN, MF , (2016) RELATIVE TIMING BETWEEN KAPPA OPIOID RECEPTOR ACTIVATION AND COCAINE DETERMINES THE IMPACT ON REWARD AND DOPAMINE RELEASE.NEUROPSYCHOPHARMACOLOGY. VOL. 41. ISSUE 4. P. 989 -1002 | 40 | 63% | 5 |
9 | BUTELMAN, ER , YUFEROV, V , KREEK, MJ , (2012) KAPPA-OPIOID RECEPTOR/DYNORPHIN SYSTEM: GENETIC AND PHARMACOTHERAPEUTIC IMPLICATIONS FOR ADDICTION.TRENDS IN NEUROSCIENCES. VOL. 35. ISSUE 10. P. 587 -596 | 57 | 55% | 43 |
10 | KELSEY, JE , VERHAAK, AMS , SCHIERBERL, KC , (2015) THE KAPPA-OPIOID RECEPTOR ANTAGONIST, NOR-BINALTORPHIMINE (NOR-BNI), DECREASES MORPHINE WITHDRAWAL AND THE CONSEQUENT CONDITIONED PLACE AVERSION IN RATS.BEHAVIOURAL BRAIN RESEARCH. VOL. 283. ISSUE . P. 16 -21 | 42 | 75% | 5 |
Classes with closest relation at Level 1 |